Contact: Nicole Napoli, firstname.lastname@example.org, 202-375-6523
WASHINGTON (Feb 26, 2018) -
Hospitals participating in the American College of Cardiology’s Patient Navigator Program, showed significant improvement in implementing performance measures that help heart attack and heart failure patients transition from the hospital to home and keep them out of the hospital longer, according to research to be presented at the ACC’s 67th Annual Scientific Session.
In the U.S., a high percentage of patients with heart failure and myocardial infarction (heart attack) are readmitted to the hospital after they have been treated. However, when patient transition care processes are implemented, the number of heart failure readmissions may decrease and in-hospital death after a heart attack may decrease, according to the research.
“Hospital readmissions are devastating to patients and their families, and patients who are readmitted have a greater chance of mortality. Additionally, readmissions take a heavy toll on our entire health care system,” said lead study author Nancy M. Albert, PhD, associate chief nursing officer, Office of Nursing Research and Innovation at Cleveland Clinic Health System in Cleveland. “We were encouraged to see a trend toward decreased heart failure readmissions when process improvements were implemented. However, improvements won’t happen automatically; strong support is needed by hospital leadership, staff, patients and all stakeholders.”
When heart patients leave the hospital, they suddenly must manage their own care. For some, there are no issues, but for many this transition can be overwhelming. For example, a typical heart patient may be required to take five to nine medications each day, at different times and in different doses. If patients don’t fully understand or follow dosage guidelines, they are at risk for returning to the hospital. Additionally, many heart patients have other health issues, such as diabetes, high blood pressure and chronic lung disease, which can make managing their own care even more difficult.
Researchers evaluated what happened one year after implementation of the American College of Cardiology Patient Navigator Program—a transition-care improvement initiative at 35 acute care hospitals in the U.S. The study focused on 17 of the 36 program processes and researchers analyzed over 14,000 patients at baseline and 3,860 patients at one year who were hospitalized for heart failure or myocardial infarction.
Transition-care improvements included six processes of care and one outcome performance measure. After one year improvement was seen across all processes. Providers were:
- 2.2 percent more likely to prescribe a life-saving heart failure medicine, called a beta-blocker
- 7.4 percent more likely to schedule a follow-up appointment before hospital discharge to occur within seven days of discharge
- 4.4 percent more likely to review home medications at admission with their patients
- 0.2 percent more likely to review medications ordered at discharge with their patients
- 4.8 percent more likely to review medications at admission and discharge with their patients
- 8.8 percent more likely to educate patients about self-care and when to contact a provider
Regarding the one outcome performance measure, the study showed that after myocardial infraction, in-hospital mortality decreased from 4 percent to 3.7 percent.
Researchers will continue to study the transition care measures to learn the measures that works best, such as assessing two-year program outcomes to better understand how a hospital’s commitment to quality efforts affects patient outcomes. In addition, other measures that were not included in the first report will be studied.
Due to the success of the first phase of the Patient Navigator Program, the ACC recently announced the launch of Patient Navigator Program: Focus MI. In the expanded program hospitals participating in the ACC’s ACTION Registry have the opportunity to transform care by sharing successful strategies, mentorship and specialized tools and resources. In addition, 15 of the original 35 hospitals from the first phase of the Patient Navigator Program will focus on identifying best practices for improving patient care and readmissions, including 30 and 90 days follow up post hospital discharge – an increasing area of focus for proposed payment and reimbursement models.
AstraZeneca is the founding sponsor of the Patient Navigator Program.
Albert will present the study, “Changes in Hospital Performance and Transition-Care Measures 1-Year after Initiation of the Patient Navigator Program,” on March 10, 2018, at 3:45 p.m. in the Heart Failure and Cardiomyopathies Moderated Poster Theater, Poster Hall, Hall A/B, Orange County Convention Center.
The ACC’s Annual Scientific Session, which in 2018 will be March 10-12 in Orlando, brings together cardiologists and cardiovascular specialists from around the world to share the newest discoveries in treatment and prevention. Follow @ACCinTouch, @ACCMediaCenter and #ACC18 for the latest news from the meeting.
The American College of Cardiology is a 52,000-member medical society that is the professional home for the entire cardiovascular care team. The mission of the College is to transform cardiovascular care and to improve heart health. The ACC leads in the formation of health policy, standards and guidelines. The College operates national registries to measure and improve care, offers cardiovascular accreditation to hospitals and institutions, provides professional medical education, disseminates cardiovascular research and bestows credentials upon cardiovascular specialists who meet stringent qualifications. For more, visit acc.org.